Integration of Xeno-Free Single-Cell Cloning in CRISPR-Mediated DNA Editing of Human iPSCs Improves Homogeneity and Methodological Efficiency of Cellular Disease Modeling

By
lbeveridge
-
0
94
The authors provided a xeno-free method for single-cell cloning of CRISPRed iPSCs achieving a clonal survival of up to 70% within seven–ten days.
[Stem Cell Reports]
Full Article